These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24683002)

  • 1. Anticoagulation versus placebo for heart failure in sinus rhythm.
    Lip GY; Shantsila E
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD003336. PubMed ID: 24683002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation versus placebo for heart failure in sinus rhythm.
    Lip GY; Wrigley BJ; Pisters R
    Cochrane Database Syst Rev; 2012 Jun; (6):CD003336. PubMed ID: 22696335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation versus placebo for heart failure in sinus rhythm.
    Shantsila E; Kozieł M; Lip GY
    Cochrane Database Syst Rev; 2021 May; 5(5):CD003336. PubMed ID: 34002371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation for heart failure in sinus rhythm.
    Lip GY; Gibbs CR
    Cochrane Database Syst Rev; 2001; (4):CD003336. PubMed ID: 11687190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm.
    Shantsila E; Lip GY
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD003333. PubMed ID: 27629776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review.
    Lip GY; Gibbs CR
    QJM; 2002 Jul; 95(7):451-9. PubMed ID: 12096150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review.
    Lip GY; Gibbs CR
    QJM; 2002 Jul; 95(7):461-8. PubMed ID: 12096151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm.
    Lip GY; Gibbs CR
    Cochrane Database Syst Rev; 2001; (4):CD003333. PubMed ID: 11687189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet agents and anticoagulants for hypertension.
    Lip GY; Felmeden DC; Dwivedi G
    Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD003186. PubMed ID: 22161375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet agents and anticoagulants for hypertension.
    Lip GY; Felmeden DC
    Cochrane Database Syst Rev; 2004; (3):CD003186. PubMed ID: 15266473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet agents and anticoagulants for hypertension.
    Shantsila E; Kozieł-Siołkowska M; Lip GY
    Cochrane Database Syst Rev; 2022 Jul; 7():CD003186. PubMed ID: 35900898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet and anticoagulation for patients with prosthetic heart valves.
    Massel DR; Little SH
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD003464. PubMed ID: 23839768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review.
    Lane DA; Raichand S; Moore D; Connock M; Fry-Smith A; Fitzmaurice DA;
    Health Technol Assess; 2013 Jul; 17(30):1-188. PubMed ID: 23880057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet therapy and anticoagulation in patients with hypertension.
    Griffin G
    Am Fam Physician; 2005 Mar; 71(5):897-9. PubMed ID: 15768617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotics in heart failure with reduced ejection fraction and normal sinus rhythm: an evidence appraisal.
    Prom R; Usedom JE; Dull RB
    Ann Pharmacother; 2014 Feb; 48(2):226-37. PubMed ID: 24259641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of the Cochrane review: Anticoagulation versus placebo for heart failure in sinus rhythm. Cochrane Database Syst Rev. 2014;3:CD003336].
    Caldeira D; Vaz-Carneiro A; Costa J
    Acta Med Port; 2014; 27(3):284-6. PubMed ID: 25017336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet and anticoagulation for patients with prosthetic heart valves.
    Little SH; Massel DR
    Cochrane Database Syst Rev; 2003; (4):CD003464. PubMed ID: 14583979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk-benefit profile of warfarin versus aspirin in patients with heart failure and sinus rhythm: a meta-analysis.
    Lee M; Saver JL; Hong KS; Wu HC; Ovbiagele B
    Circ Heart Fail; 2013 Mar; 6(2):287-92. PubMed ID: 23264446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral anticoagulation therapy in heart failure patients in sinus rhythm: a systematic review and meta-analysis.
    Rengo G; Pagano G; Squizzato A; Moja L; Femminella GD; de Lucia C; Komici K; Parisi V; Savarese G; Ferrara N; Perrone-Filardi P; Leosco D
    PLoS One; 2013; 8(1):e52952. PubMed ID: 23301006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation.
    Bruins Slot KM; Berge E
    Cochrane Database Syst Rev; 2013 Aug; (8):CD008980. PubMed ID: 23925867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.